Megan Aarnio Peterson, Ph.D.
About Megan Aarnio Peterson, Ph.D.
Megan Aarnio Peterson, Ph.D., is a Clinical Trial Manager at Sangamo Therapeutics, Inc., with a Ph.D. in Biochemistry and Molecular Biology from the University of Georgia. She has extensive experience managing global clinical trials, particularly in rare and orphan disorders.
Work at Sangamo Therapeutics
Megan Aarnio Peterson, Ph.D., has been serving as a Clinical Trial Manager at Sangamo Therapeutics, Inc. since 2020. In this role, she is responsible for overseeing clinical trials, particularly focusing on rare and orphan disorders. Her position is remote, allowing her to manage global clinical trial operations effectively. Prior to her current tenure, she briefly worked at Sangamo Therapeutics in 2020 for five months.
Education and Expertise
Megan Aarnio Peterson holds a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology, which she obtained from the University of Georgia from 2011 to 2017. Her educational background also includes a Bachelor of Science (BS) in General Biology from the University of Georgia's Franklin College of Arts and Sciences, completed from 2005 to 2009. This academic foundation supports her expertise in managing clinical trials.
Background
Megan Aarnio Peterson has a solid educational and professional background in the life sciences. She studied Biochemistry and Molecular Biology for her Ph.D. and General Biology for her undergraduate degree. Her career includes significant experience in clinical trial management, particularly in the context of rare and orphan disorders, which enhances her qualifications in the field.
Previous Experience at Medpace
Before joining Sangamo Therapeutics, Megan Aarnio Peterson worked as a Clinical Trial Manager at Medpace from 2018 to 2020. During her time at Medpace, she gained valuable experience in managing clinical trials, contributing to her expertise in the operational aspects of clinical research.